The Israeli-developed treatment uses RNA molecules to silence mutated KRAS genes and will be tested alongside standard therapy in patients with locally advanced disease.
- News
- Views
- Topics
- Sources
- Israel in Maps
- Welcome to Zion
- About
Select Page




